Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25116265 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Aleksandra Kicman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Aesthetic Medicine, The Faculty of Pharmacy, Medical University of Białystok, 15-267 Białystok, Poland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, CA-125 Antigen, WAP Four-Disulfide Core Domain Protein 2, Algorithms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Bialystok.
Abstract (Originalsprache)
Ovarian cancer (OC) has an unfavorable prognosis. Due to the lack of effective screening tests, new diagnostic methods are being sought to detect OC earlier. The aim of this study was to evaluate the concentration and diagnostic utility of selected matrix metalloproteinases (MMPs) as OC markers in comparison with HE4, CA125 and the ROMA algorithm. The study group consisted of 120 patients with OC; the comparison group consisted of 70 patients with benign lesions and 50 healthy women. MMPs were determined via the ELISA method, HE4 and CA125 by CMIA. Patients with OC had elevated levels of MMP-3 and MMP-11, similar to HE4, CA125 and ROMA values. The highest SE, SP, NPV and PPV values were found for MMP-26, CA125 and ROMA in OC patients. Performing combined analyses of ROMA with selected MMPs increased the values of diagnostic parameters. The topmost diagnostic power of the test was obtained for MMP-26, CA125, HE4 and ROMA and performing combined analyses of MMPs and ROMA enhanced the diagnostic power of the test. The obtained results indicate that the tested MMPs do not show potential as stand-alone OC biomarkers, but can be considered as additional tests to raise the diagnostic utility of the ROMA algorithm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Aesthetic Medicine, The Faculty of Pharmacy, Medical University of Białystok, 15-267 Białystok, Poland.
- Department of Perinatology, University Clinical Hospital of Bialystok, 15-276 Białystok, Poland.
- Department of Population Medicine and Lifestyle Diseases Prevention, The Faculty of Medicine, Medical University of Białystok, 15-269 Białystok, Poland.
- Department of Haematological Diagnostics, The Faculty of Medicine, Medical University of Białystok, 15-269 Białystok, Poland.
- Department of Psychiatry, The Faculty of Medicine, Medical University of Białystok, 15-272 Białystok, Poland.
- University Cancer Center, University Clinical Hospital of Bialystok, 15-276 Białystok, Poland.
ORCID-Profile: Aleksandra Kicman, Ewa Grażyna Będkowska, Rafał Marecki, Paweł Knapp, Marek Niczyporuk, Sławomir Ławicki
Förderung
- Medical University of Bialystok
Zitieren
APA
Kicman, A., Gacuta, E., Kulesza, M., Będkowska, E. G., Marecki, R., Klank-Sokołowska, E., Knapp, P., Niczyporuk, M., & Ławicki, S. (2024). Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116265
Vancouver
Kicman A, Gacuta E, Kulesza M, Będkowska EG, Marecki R, Klank-Sokołowska E, et al. Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25116265
BibTeX
@article{Kicman2024,
author = {Kicman, Aleksandra and Gacuta, Ewa and Kulesza, Monika and Będkowska, Ewa Grażyna and Marecki, Rafał and Klank-Sokołowska, Ewa and Knapp, Paweł and Niczyporuk, Marek and Ławicki, Sławomir},
title = {Diagnostic Utility of Selected Matrix Metalloproteinases (MMP-2, MMP-3, MMP-11, MMP-26), HE4, CA125 and ROMA Algorithm in Diagnosis of Ovarian Cancer},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25116265}
}
EUVIMED